Literature DB >> 20439655

Provider factors associated with intramedullary nail use for intertrochanteric hip fractures.

Mary L Forte1, Beth A Virnig, Lynn E Eberly, Marc F Swiontkowski, Roger Feldman, Mohit Bhandari, Robert L Kane.   

Abstract

BACKGROUND: Intramedullary nails provide no clear outcomes benefit in the majority of patients with intertrochanteric hip fracture, yet their use in the United States continues to increase. Non-patient factors that are associated with intramedullary nail use among Medicare patients have not been examined. The goal of this study was to identify the surgeon and hospital characteristics that were associated with the use of intramedullary nails compared with plate-and-screw devices among elderly Medicare patients with intertrochanteric hip fractures.
METHODS: Medicare beneficiaries who were sixty-five years of age or older and underwent inpatient surgery to treat an intertrochanteric femoral fracture with use of an intramedullary nail or a plate-and-screw device were identified from the United States Medicare files for 2000 to 2002. Surgeon and hospital characteristics from the Medicare provider enrollment files were merged with the claims. Generalized linear mixed models with fixed and random effects modeled the association between surgeon and hospital factors and intramedullary nail use (compared with plate and screws), controlling for patient age, sex, and race; subtrochanteric fracture; Charlson comorbidity score; nursing home residence; and Medicaid-administered assistance. The adjusted odds ratios of receiving an intramedullary nail by year, surgeon, and hospital factors are reported.
RESULTS: There were 192,365 claims for surgery to treat an intertrochanteric hip fracture that met the inclusion criteria and matched with surgeon and hospital information. There were 15,091 surgeons who performed intertrochanteric hip fracture surgeries in Medicare patients in 3480 hospitals between March 1, 2000, and December 31, 2002. The surgeon factors associated with intramedullary nail use include younger surgeon age (less than forty-five years old), an osteopathy degree, and operating at more than one hospital. The hospital factors associated with intramedullary nail use include a higher volume of intertrochanteric hip fracture surgeries, teaching hospital status, and having resident assistance during surgery. Surgeon factors improved the model fit more than hospital factors.
CONCLUSIONS: The use of intramedullary nails was strongly associated with early-career surgeons and surgeon training programs. Our findings suggest that orthopaedic faculty at teaching hospitals and younger surgeons may be selecting orthopaedic implants on the basis of factors other than clinical outcomes evidence. We expect that intramedullary nail use will continue to increase as long as new surgeons are preferentially trained in intramedullary nailing procedures and surgeon reimbursement remains insulated from the treating hospital's burden of their choices for higher cost devices under the Medicare payment system.

Entities:  

Mesh:

Year:  2010        PMID: 20439655     DOI: 10.2106/JBJS.I.00295

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  20 in total

1.  Prospective randomised study comparing screw versus helical blade in the treatment of low-energy trochanteric fractures.

Authors:  Richard Stern; Anne Lübbeke; Domizio Suva; Hermes Miozzari; Pierre Hoffmeyer
Journal:  Int Orthop       Date:  2011-03-10       Impact factor: 3.075

2.  Short versus long intramedullary nails for treatment of intertrochanteric femur fractures (AO 31-A1 and AO 31-A2): a systematic review.

Authors:  Pernille Bovbjerg; Lonnie Froberg; Hagen Schmal
Journal:  Eur J Orthop Surg Traumatol       Date:  2019-07-18

3.  Convergence of outcomes for hip fracture fixation by nails and plates.

Authors:  Foster Chen; Zhong Wang; Timothy Bhattacharyya
Journal:  Clin Orthop Relat Res       Date:  2012-11-27       Impact factor: 4.176

Review 4.  Recent aspects on outcomes in geriatric fracture patients.

Authors:  N Suhm; D Rikli; S Schaeren; P Studer; M Jakob; S L Kates
Journal:  Osteoporos Int       Date:  2010-11-06       Impact factor: 4.507

5.  Long-term results after treatment of pertrochanteric femoral fractures with percutaneous compression plate (PCCP).

Authors:  E Crespo; S Gómez; V Palacios; J Galvez; J M Tenías; I Cano; R Peñuela; A Arcas; R Crespo
Journal:  Eur J Orthop Surg Traumatol       Date:  2016-06-28

6.  Which Fixation Device is Preferred for Surgical Treatment of Intertrochanteric Hip Fractures in the United States? A Survey of Orthopaedic Surgeons.

Authors:  Emily Niu; Arthur Yang; Alex H S Harris; Julius Bishop
Journal:  Clin Orthop Relat Res       Date:  2015-07-25       Impact factor: 4.176

7.  Case report: unique failure of a Synthes TFNA fenestrated lag screw in a peritrochanteric nonunion.

Authors:  Kevin P Smidt; Kevin J Perry; Lincoln K Andre; Brad J Chauvin; Steve Kautz; Patrick A Massey; R Shane Barton
Journal:  OTA Int       Date:  2022-03-18

Review 8.  Comparative outcome of PFNA, Gamma nails, PCCP, Medoff plate, LISS and dynamic hip screws for fixation in elderly trochanteric fractures: a systematic review and network meta-analysis of randomized controlled trials.

Authors:  Alisara Arirachakaran; Tanawat Amphansap; Pichaya Thanindratarn; Peerapong Piyapittayanun; Phutsapong Srisawat; Jatupon Kongtharvonskul
Journal:  Eur J Orthop Surg Traumatol       Date:  2017-04-22

9.  A National Comparison of Operative Outcomes of New and Experienced Surgeons.

Authors:  Rachel R Kelz; Morgan M Sellers; Bijan A Niknam; James E Sharpe; Paul R Rosenbaum; Alexander S Hill; Hong Zhou; Lauren L Hochman; Karl Y Bilimoria; Kamal Itani; Patrick S Romano; Jeffrey H Silber
Journal:  Ann Surg       Date:  2021-02-01       Impact factor: 13.787

10.  Breakage of a third generation gamma nail: a case report and review of the literature.

Authors:  Takashi Iwakura; Takahiro Niikura; Sang Yang Lee; Yoshitada Sakai; Kotaro Nishida; Ryosuke Kuroda; Masahiro Kurosaka
Journal:  Case Rep Orthop       Date:  2013-05-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.